SLU7 antibody (AA 301-400)
Quick Overview for SLU7 antibody (AA 301-400) (ABIN1385975)
Target
See all SLU7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 301-400
-
Purpose
- SLU7 Polyclonal Antibody
-
Cross-Reactivity
- Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SLU7
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- SLU7 (SLU7 Splicing Factor Homolog (SLU7))
-
Alternative Name
- SLU7
-
Target Type
- Influenza Protein
-
Background
-
Synonyms: 9G8, hSlu7, MGC9280, Pre mRNA splicing factor SLU7, Pre-mRNA-splicing factor slu7, SLU 7, SLU-7, slu7, SLU7 splicing factor homolog S. cerevisiae, SLU7 splicing factor homolog, SLU7_HUMAN, Step II splicing factor SLU7, Zinc knuckle mot containing.
Background: Participates in the second catalytic step of pre-mRNA splicing, when the free hydroxyl group of exon I attacks the 3'-splice site to generate spliced mRNA and the excised lariat intron. Required for holding exon 1 properly in the spliceosome and for correct AG identification when more than one possible AG exists in 3'-splicing site region. May be involved in the activation of proximal AG. Probably also involved in alternative splicing regulation.
-
Gene ID
- 10569
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, SARS-CoV-2 Protein Interactome
Target
-